Advertisement'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise ConcernsPlay04:14Download AudioSeptember 04, 2020Tom DreisbachfacebookEmailModerna, based in Cambridge, Mass., has reached phase three trials for its coronavirus vaccine. At the same time, its executives have sold tens of millions of dollars worth of stock, which has led to intense criticism of the company. (Getty Images)
